Trials / Conditions / Small Lymphocytic Leukemia

Small Lymphocytic Leukemia

11 registered clinical trials studyying Small Lymphocytic Leukemia — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously U NCT07321652	Alliance for Clinical Trials in Oncology	Phase 3
Completed	REfractorinesS to Ibrutinib BTKi and Systemic Targeted Therapy NCT05621148	French Innovative Leukemia Organisation	—
Terminated	Acalabrutinib in Combination With R-ICE For Relapsed or Refractory Lymphoma NCT04189952	University of Miami	Phase 2
Completed	BR101801 in Adult Patients With Advanced Hematologic Malignancies(Phase I) NCT04018248	Boryung Pharmaceutical Co., Ltd	Phase 1
Completed	Ibrutinib as Early Therapy in Chronic Lymphocytic Leukemia (CLL) NCT03207555	M.D. Anderson Cancer Center	Phase 2
Completed	A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies NCT03329950	Celldex Therapeutics	Phase 1
Withdrawn	Pharmacokinetics (PK), Pharmacodynamics (PD), Safety, Tolerability of Multiple Dose Regimens of MT-3724 for th NCT02556346	Molecular Templates, Inc.	Phase 1
Terminated	Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL NCT02361346	Molecular Templates, Inc.	Phase 1 / Phase 2
Completed	Pyrimethamine for the Treatment of Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma NCT01066663	Dana-Farber Cancer Institute	Phase 1 / Phase 2
Terminated	Dose Escalation Study of Revlimid With Fludarabine-Rituximab for CLL/SLL NCT00543114	Dana-Farber Cancer Institute	Phase 1
Unknown	Study of AQ4N in Patients With Non Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Leuk NCT00109356	Novacea	Phase 1 / Phase 2